Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Haubitz

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
The Journal of Rheumatology|September 18, 2012
Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID)Petra Roll, Eva Ostermeier, Marion Haubitz, et al.
Frontiers in Immunology|September 28, 2020
Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney TransplantationChristian Morath, Bernd Döhler, Florian Kälble, et al.
Plos One|January 27, 2012
Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitisPaul A Monach, Philipp Kümpers, Alexander Lukasz, et al.
Transplantation|February 13, 2019
Equally Interchangeable? How Sex and Gender Affect TransplantationAnette Melk, Birgit Babitsch, Bianca Borchert-Mörlins, et al.
Annals of the Rheumatic Diseases|August 2, 2012
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritisGeorge K Bertsias, Maria Tektonidou, Zahir Amoura, et al.
Journal of the American Society of Nephrology : JASN|January 16, 2015
Diagnosis and Prediction of CKD Progression by Assessment of Urinary PeptidesJoost P Schanstra, Petra Zürbig, Alaa Alkhalaf, et al.
Molecular & Cellular Proteomics : MCP|July 10, 2010
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney diseaseDavid M Good, Petra Zürbig, Angel Argilés, et al.
Science Translational Medicine|August 27, 2010
Recommendations for biomarker identification and qualification in clinical proteomicsHarald Mischak, Günter Allmaier, Rolf Apweiler, et al.
Arthritis Research & Therapy|May 17, 2011
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)Hans-Peter Tony, Gerd Burmester, Hendrik Schulze-Koops, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
The Journal of Rheumatology|September 18, 2012
Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID)Petra Roll, Eva Ostermeier, Marion Haubitz, et al.
Frontiers in Immunology|September 28, 2020
Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney TransplantationChristian Morath, Bernd Döhler, Florian Kälble, et al.
Plos One|January 27, 2012
Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitisPaul A Monach, Philipp Kümpers, Alexander Lukasz, et al.
Transplantation|February 13, 2019
Equally Interchangeable? How Sex and Gender Affect TransplantationAnette Melk, Birgit Babitsch, Bianca Borchert-Mörlins, et al.
Annals of the Rheumatic Diseases|August 2, 2012
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritisGeorge K Bertsias, Maria Tektonidou, Zahir Amoura, et al.
Journal of the American Society of Nephrology : JASN|January 16, 2015
Diagnosis and Prediction of CKD Progression by Assessment of Urinary PeptidesJoost P Schanstra, Petra Zürbig, Alaa Alkhalaf, et al.
Molecular & Cellular Proteomics : MCP|July 10, 2010
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney diseaseDavid M Good, Petra Zürbig, Angel Argilés, et al.
Science Translational Medicine|August 27, 2010
Recommendations for biomarker identification and qualification in clinical proteomicsHarald Mischak, Günter Allmaier, Rolf Apweiler, et al.
Arthritis Research & Therapy|May 17, 2011
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)Hans-Peter Tony, Gerd Burmester, Hendrik Schulze-Koops, et al.
Pageof 8